Le Lézard
Classified in: Health, Science and technology
Subject: Contract/Agreement

Medidata and Mapi Research Trust (MRT) Announce Strategic Collaboration to Standardize eCOA Global Library of Questionnaires


Medidata (NASDAQ: MDSO) and Mapi Research Trust today announced a new critical mission: to build a digital, global library of pre-configured and pre-approved eCOA (clinical outcomes assessment) questionnaires. The collaboration will create reusable versions of MRT distributed questionnaires in Medidata Rave eCOA, collecting COA data from hundreds of studies each year on the Medidata platform.

"This new collaboration with MRT will seek to solve two major eCOA implementation struggles that affect the pharmaceutical industry - the rework involved in building the same questionnaire in multiple studies for different sponsors, and the timelines required for deploying translated versions across global trials," said Glen de Vries, president, co-founder, Medidata. "MRT's licensing and author relationships, combined with Medidata's expertise and eCOA solution, will drive significant efficiencies in study management, empowering sponsors to create more patient-centric clinical trials."

The collaboration will allow Medidata and MRT to engage with instrument authors and study sponsors, resulting in questionnaires that are pre-approved, translated for global implementations, and archived for future use. Based on this innovative approach, the comprehensive new eCOA library will include:

"Industry timelines from kick-off to go-live for eCOA studies have long been stuck at 12 to 16 weeks, because of repeated efforts rebuilding the same forms and translations over and over for different studies," says Katrin Conway, Managing Director of Mapi Research Trust. "The Medidata and MRT global eCOA Library seeks to cut these timelines by as much as 50-60% by building a library of pre-approved questionnaires that Medidata customers on the Rave platform of products can use."

About Medidata

Medidata is leading the digital transformation of life sciences, with the world's most-used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by industry experts, Medidata helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata and its companies, Acorn AI and SHYFT, serve more than 1,300 customers and partners worldwide and empower more than 150,000 certified users every day to create hope for millions of patients. Discover the future of life science: www.medidata.com

About Mapi Research Trust:

Mapi Research Trust was created as a non-profit arm of Mapi Group which was acquired by ICON plc in 2017, creating the world's second largest provider of late phase services. Mapi Research Trust works in collaboration with academic researchers, life-science companies and regulatory bodies to support the industry in reducing the burden of implementing COA in Health research. It is the largest curator of Clinical Outcomes Assessments (COA) and their translations, the largest single COA licensing provider and the most trusted name in distribution of COA instruments representing over 350 exclusive questionnaires. Visit http://mapi-trust.org/ for more information.


These press releases may also interest you

at 18:55
Resverlogix Corp. ("Resverlogix" or the "Company") is pleased to announce the Company will host a Corporate Update Conference Call and Webcast on June 10th, 2020 at 9 am MT/11 am ET. The Company also announces its participation at the 57th ERA-EDTA...

at 18:05
Euro Tech Holdings Company Limited today reported financial results for the 12-month period ended December 31, 2019 ("Fiscal 2019"). The Company's revenues for Fiscal 2019 were approximately US$17,399,000, an approximate 13.5% decrease compared to...

at 18:00
Fang Holdings Limited ("Fang" or the "Company"), a leading real estate Internet portal in China, today announced that the ratio of American depositary shares ("ADSs") representing its Class A ordinary shares is being amended from one (1) ADS...

at 17:52
Course Hero today announced a $500,000 donation for student aid to the Dear Class of 2020 Fund, immediately doubling its commitment to provide targeted financial assistance to students affected by the COVID-19 pandemic. The investment will be...

at 17:47
The U.S. Food and Drug Administration today continued to take action in the ongoing response to the COVID-19 pandemic: The FDA issued an updated FDA COVID-19 Response At-A-Glance Summary that provides a quick look at facts, figures and highlights of...

at 17:46
NASA has finalized the contract for the initial crew module of the agency's Gateway lunar orbiting outpost. Orbital Science...



News published on 12 september 2019 at 08:35 and distributed by: